✦ LIBER ✦

Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: Results of the Dutch Rheumatoid Arthritis Monitoring registry

✍ Scribed by Laurien Buitinga; Louise M. A. Braakman-Jansen; Erik Taal; Wietske Kievit; Henk Visser; Piet L. C. M. van Riel; Mart A. F. J. van de Laar

Book ID: 111991798
Publisher: Wiley (John Wiley & Sons)
Year: 2012
Tongue: English
Weight: 119 KB
Volume: 64
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.21619

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors for the 5-year risk of seriou

Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

✍ van Dartel, S. A. A.; Fransen, J.; Kievit, W.; Dutmer, E. A. J.; Brus, H. L. M.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 104 KB

Incidence and Risk Factors for Serious I

Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

✍ KOMANO, Y.; TANAKA, M.; NANKI, T.; KOIKE, R.; SAKAI, R.; KAMEDA, H.; NAKAJIMA, A 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 337 KB

Individualized monitoring of drug bioava

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab

✍ Klaus Bendtzen; Pierre Geborek; Morten Svenson; Lotta Larsson; Meliha C. Kapetan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## Objective Infliximab, an anti–tumor necrosis factor α (anti‐TNFα) antibody, is effective in the treatment of several immunoinflammatory diseases. However, many patients experience primary or secondary response failure, suggesting that individualization of treatment regimens may be b

Results of anakinra treatment in rheumat

Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor α blockade: Comment on the article by Buch et al

✍ Tore Saxne; Lotta Larsson; Pierre Geborek 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Correlation of C-reactive protein haplot

Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

✍ Darren Plant, Ibrahim Ibrahim, Mark Lunt, Stephen Eyre, Edward Flynn, Kimme L Hy 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 170 KB